Publications

This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting in November 2024.

This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting in September 2024

This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting in June 2024.

Health Ministers met today in Sydney and discussed ongoing management of shortages of IV fluids.

This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting on 29 February and 1 March 2024.

This report presents national secondary student use use of tobacco and e-cigarettes from the 2022–2023 Australian secondary school students tobacco and e-cigarettes survey.

This report presents national secondary student use of alcohol and other substances from the 2022–2023 Australian secondary school students alcohol and drug survey.

This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting on 23 and 24 November 2023.

The Australian Government response to the Parliamentary Joint Committee on Law Enforcement Inquiry report on public communications campaigns targeting drug and substance abuse.

Promotional postcard containing important information and details for further reading regarding the Take Home Naloxone Program.

Postcard for pharmacists regarding the THN program. Includes information about how to appropriately discuss THN with patients.

A sticker that healthcare providers can display to highlight the availability of Take Home Naloxone.

Promotional poster containing important information and details for further reading regarding the Take Home Naloxone Program.

A sticker that healthcare providers can display to highlight the availability of Take Home Naloxone.

Promotional poster containing important information and details for further reading regarding the Take Home Naloxone Program. Includes wording specific for pharmacy sites.

Promotional poster containing important information and details for further reading regarding the Take Home Naloxone Program.

This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting on 29 and 30 August 2023.

A summary of findings from consultations undertaken from April to June 2023. The report builds on a previous 2021 consultation to inform the Government’s approach to deliver additional alcohol and other drug treatment services across the four longest running former Cashless Debit Card trial sites.

This infographic provides a plan for the research and analysis that will inform the HTA Policy and Methods Review.

This document provides an update from the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) after their meeting on 6 and 7 June 2023.

The National Quality Framework for Drug and Alcohol Treatment Services sets a national quality benchmark which consumers can expect from alcohol and other drug treatment providers.

This report outlines the findings to inform the grant funding decision-making process for the delivery of alcohol and other drug treatment services for four Cashless Debit Card (CDC) trial sites: Ceduna (SA), Bundaberg-Hervey Bay (QLD), East Kimberley and the Goldfields (WA).

An update from the Health Technology Assessment Policy and Methods Review Reference Committee following its meeting on 27 January 2023.

Health Technology Assessment Policy and Methods Review Reference Committee agenda for the 1st meeting on 1 December 2022.

Health Technology Assessment Policy and Methods Review Reference Committee agenda for the 2nd meeting on 19 December 2022.